Brief: Biomea Fusion Announces Poster Presentations Of Icovamenib At The American Diabetes Association (Ada) 86Th Scientific Sessions
05/05/2026 23:25
May 5 (Reuters) - Biomea Fusion Inc BMEA.O: BIOMEA FUSION ANNOUNCES POSTER PRESENTATIONS OF ICOVAMENIB AT THE AMERICAN DIABETES ASSOCIATION (ADA) 86TH SCIENTIFIC SESSIONS Source text: ID:nGNX44G15T Further company coverage: BMEA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biomea Fusion
See all newsUS RESEARCH ROUNDUP-BlackRock, Microsoft, TransDigm Group
Brief: Biomea Fusion Announces Phase 1 Results For Bmf-650, Its Investigational Next-Generation Oral Small Molecule Glp-1 Receptor Agonist
Brief: Biomea Fusion To Announce Phase I Results For Bmf-650, Its Next-Generation Oral Small-Molecule Glp-1 Receptor Agonist
Brief: Biomea Fusion Announces Termination Of Proposed Public Offering Of Securities
Brief: Biomea Fusion Announces Completion Of Enrollment In Covalent-211 Phase Ii Trial Of Icovamenib In Insulin-Deficient Type 2 Diabetes